ArthurAckermanWinerMD
Internal Medicine • Fairfax, VAHospital Medicine/Hospitalist, Hematology/Oncology
NYU Langone
Dr. Winer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724Fax+1 571-472-0241
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
NYU Grossman School of MedicineResidency, Internal Medicine, 2013 - 2016- New York University School of MedicineClass of 2013
Certifications & Licensure
VA State Medical License 2020 - 2026
PA State Medical License 2017 - 2021
NY State Medical License 2014 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsTreatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced Approach.Arthur Winer, Efrat Dotan
Current Treatment Options in Oncology. 2021-10-01 - Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Tr...Pooja Ghatalia, Chad H Smith, Arthur Winer, Jiangtao Gou, Lesli A Kiedrowski
Frontiers in Oncology. 2021-01-01 - 36 citationsDual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch ...Arthur Winer, Pooja Ghatalia, Nicole Bubes, Fern Anari, Asya Varshavsky
The Oncologist. 2019-11-01
Lectures
- Gemcitabine and nab-paclitaxel in older adults with metastatic pancreatic cancer: Are two doses per cycle enough?ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- A phase ib trial to evaluate the safety and efficacy of quinacrine plus capecitabine in patients with refractory metastatic colorectal cancer.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Press Mentions
Symptoms and Screenings for Cancers of the Stomach, Esophagus and LiverJanuary 20th, 2023- Colorectal Cancer Screening Should Begin at Age 45July 7th, 2021
- Think Twice Before Dose-Reducing Gemcitabine plus Nab-PaclitaxelNovember 9th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
